Dario Altieri

Dario Altieri is a renowned oncologist and scientist known for his significant contributions to the field of cancer research. He is currently serving as the President and CEO of the Wistar Institute, a leading biomedical research facility in Philadelphia, Pennsylvania.

Early Life and Education[edit | edit source]

Dario Altieri was born in Italy and completed his early education there. He pursued his medical degree from the University of Milan, one of the top-ranking universities in Italy. After completing his medical degree, he moved to the United States for his postgraduate studies.

Career[edit | edit source]

Altieri began his career as a research associate at the National Cancer Institute (NCI), where he worked on various cancer research projects. His work at NCI laid the foundation for his future research in the field of oncology.

In 2010, Altieri was appointed as the Director of the Cancer Center at the Wistar Institute. Under his leadership, the institute has made significant advancements in cancer research. His research primarily focuses on the molecular mechanisms of tumor progression and resistance to therapy.

Research and Contributions[edit | edit source]

Altieri's research has led to the discovery of several key proteins involved in cancer progression. His work has significantly contributed to our understanding of the molecular mechanisms of cancer and has paved the way for the development of new therapeutic strategies.

One of his most notable contributions is the discovery of the protein Survivin, which plays a crucial role in cancer cell survival and resistance to therapy. This discovery has opened up new avenues for the development of targeted cancer therapies.

Awards and Recognition[edit | edit source]

Altieri's contributions to cancer research have earned him numerous awards and recognition. He is a recipient of the Outstanding Investigator Award from the National Institutes of Health (NIH) and the MERIT Award from the National Cancer Institute.